AZOPT
AZOPT
Approved
DIN Number
02238873
Drug Class
Human
Market Date
Nov 11, 1998
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238873
AIG Number0134800001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EC04 BRINZOLAMIDE
Product Specifications
Dosage FormSuspension
Route of AdministrationOphthalmic
AHFS Classification52:40.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
BRINZOLAMIDEActive
Strength: 1 % / W/V
Monograph: BRINZOLAMIDE